Search research articles
Contact Us
Filters
Showing results (91-100 of 102) with videos related to
Page
of 11
Sort By:
Brain Research
|
December 31, 1997
Inhibition of striatal energy metabolism produces cell loss in the ipsilateral substantia nigra
P K Sonsalla, L Manzino, C M Sinton, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
May 1, 1988
The human locus coeruleus: computer reconstruction of cellular distribution
D C German, B S Walker, K Manaye, et al.
The Journal of Comparative Neurology
|
April 12, 2001
Selective neurodegeneration, without neurofibrillary tangles, in a mouse model of Niemann-Pick C disease
D C German, E M Quintero, C L Liang, et al.
Neuroreport
|
August 15, 1994
Low dopamine transporter mRNA levels in midbrain regions containing calbindin
M K Sanghera, K F Manaye, C L Liang, et al.
Neurodegeneration : a Journal for Neurodegenerative Disorders, Neuroprotection, and Neuroregeneration
|
December 1, 1996
The neurotoxin MPTP causes degeneration of specific nucleus A8, A9 and A10 dopaminergic neurons in the mouse
D C German, E L Nelson, C L Liang, et al.
Neuroscience
|
April 13, 1999
Quantification of cholinergic and select non-cholinergic mesopontine neuronal populations in the human brain
K F Manaye, R Zweig, D Wu, et al.
Journal of Neural Transmission
|
January 1, 1979
Dopaminergic neuronal responses to a non-amphetamine CNS stimulant
D C German, H Harden, M K Sanghera, et al.
Brain Research
|
July 10, 1989
1-Methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine (2'CH3-MPTP)-induced degeneration of mesostriatal dopaminergic neurons in the mouse: biochemical and neuroanatomical studies
K F Manaye, P K Sonsalla, G Barnett, et al.
Brain Research. Molecular Brain Research
|
March 1, 1996
The neurotoxin MPTP increases calbindin-D28k levels in mouse midbrain dopaminergic neurons
M C Ng, A M Iacopino, E M Quintero, et al.
Brain Research Bulletin
|
May 1, 1984
Effects of zoxazolamine and related centrally acting muscle relaxants on nigrostriatal dopaminergic neurons
R T Matthews, B A McMillen, S G Speciale, et al.
Page
of 11
Search research articles
Search
Showing results (91-100 of 102) with videos related to
Sort By:
Page
of 11
Brain Research
|
December 31, 1997
Inhibition of striatal energy metabolism produces cell loss in the ipsilateral substantia nigra
P K Sonsalla, L Manzino, C M Sinton, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
May 1, 1988
The human locus coeruleus: computer reconstruction of cellular distribution
D C German, B S Walker, K Manaye, et al.
The Journal of Comparative Neurology
|
April 12, 2001
Selective neurodegeneration, without neurofibrillary tangles, in a mouse model of Niemann-Pick C disease
D C German, E M Quintero, C L Liang, et al.
Neuroreport
|
August 15, 1994
Low dopamine transporter mRNA levels in midbrain regions containing calbindin
M K Sanghera, K F Manaye, C L Liang, et al.
Neurodegeneration : a Journal for Neurodegenerative Disorders, Neuroprotection, and Neuroregeneration
|
December 1, 1996
The neurotoxin MPTP causes degeneration of specific nucleus A8, A9 and A10 dopaminergic neurons in the mouse
D C German, E L Nelson, C L Liang, et al.
Neuroscience
|
April 13, 1999
Quantification of cholinergic and select non-cholinergic mesopontine neuronal populations in the human brain
K F Manaye, R Zweig, D Wu, et al.
Journal of Neural Transmission
|
January 1, 1979
Dopaminergic neuronal responses to a non-amphetamine CNS stimulant
D C German, H Harden, M K Sanghera, et al.
Brain Research
|
July 10, 1989
1-Methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine (2'CH3-MPTP)-induced degeneration of mesostriatal dopaminergic neurons in the mouse: biochemical and neuroanatomical studies
K F Manaye, P K Sonsalla, G Barnett, et al.
Brain Research. Molecular Brain Research
|
March 1, 1996
The neurotoxin MPTP increases calbindin-D28k levels in mouse midbrain dopaminergic neurons
M C Ng, A M Iacopino, E M Quintero, et al.
Brain Research Bulletin
|
May 1, 1984
Effects of zoxazolamine and related centrally acting muscle relaxants on nigrostriatal dopaminergic neurons
R T Matthews, B A McMillen, S G Speciale, et al.
Page
of 11